Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: Correlation with DNA ploidy and S-phase fraction by flow cytometry

Oncology

Volumn 71, Issue 5-6, 2007, Pages 411-416

  Singh, Madhulika ^a   Prasad, Sahdeo ^a   Kalra, Neetu ^a   Singh, Uma ^a   Shukla, Yogeshwer ^a,b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Cell cycle; Cervical dysplasia; DNA ploidy; Flow cytometry; Nucleolar organizer region; S phase; Silver stained nucleolar organizer regions

Indexed keywords

DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CELL CYCLE S PHASE; CELL FRACTIONATION; CHROMOSOME NOR; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SILVER STAINING; SURVIVAL RATE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA;

ADULT; AGED; ANTIGENS, NUCLEAR; CELL COUNT; CERVIX UTERI; DNA; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PLOIDIES; PROGNOSIS; S PHASE; SILVER STAINING; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 35348885707     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107773     Document Type: Article

References (42)

1. Tiffen J, Mahon SM: Cervical cancer: what should we tell women about screening? Clin J Oncol Nurs 2006;10:527-531.
2. Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC: Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 2006;210:412-419.
3. Lin ZH, Liu MZ, Zhao YW, Wu QY, Liu SP, Kim I: Study of p16(INK4A) expression and DNA ploidy in HPV-negative cervical cancers and precursors. Zhonghua Bing Li Xue Za Zhi 2006;35:412-416.
4. Bollmann R, Mehes G, Speich N, Schmitt C, Bollmann M: Aberrant, highly hyperdiploid cells in human papillomavirus-positive;abnormal cytologic samples are associated with progressive lesions of the uterine cervix. Cancer 2005;105:96-100.
5. Gasinska A, Urbanski K, Gruchala A, Biesaga B, Kojs Z: A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma. Neoplasma 2002;49:379-386.
6. Kashyap V, Das BC: DNA aneuploidy and infection of human papillomavirus type 16 in preneoplastic lesions of the uterine cervix: correlation with progression to malignancy. Cancer Lett 1998;123:47-52.
7. Bollmann R, Mehes G, Torka R, Speich N, Schmitt C, Bollmann M: Human papillomavirus typing and DNA ploidy determination of squamous intraepithelial lesions in liquid-based cytologic samples. Cancer 2003;99:57-62.
8. Lorenzato M, Caudroy S, Bronner C, Evrard G, Simon M, Durlach A, Birembaut P, Clavel C: Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol 2005;36:1101-1107.
9. Melsheimer P, Klaes R, von Knebel Doeberitz M, Bastert G: Prospective clinical study comparing DNA flow cytometry and HPV typing as predictive tests for persistence and progression of CIN I/II. Cytometry 2001;46:166-171.
10. Rocher AE, Gonzalez A, Palaoro LA, Blanco AM: Usefulness of AgNOR technique and CEA expression in atypical metaplastic cells from cervical smears. Anal Quant Cytol Histol 2006;28:130-136.
11. Pahuja S, Choudhury M, Gupta U: AgNOR counts in exfoliative cytology smears of preinvasive and invasive squamous epithelial lesions of cervix. J Cytology 2003;20:177-179.
12. Chung T, Cheung TH, Wong FS, Wong UF: Ki-67 and AgNOR staining in squamous cell carcinoma of the cervix: a comparison. Gynecol Obstet Invest 1994;37:127-129.
13. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ: Improvement in the staining and the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histocheml J 1986;18:5-14.
14. Morton CC, Brown JA, Holmes WM, Nance WE, Wolf B: Stain intensity of human nucleolus organizer region reflects incorporation of uridine into mature ribosomal RNA. Exp Cell Res 1983;1415:405-413.
15. Hubbell HR: Silver staining as an indicator of active ribosomal genes. Stain Technol 1985;60:285-294.
16. Sirri V, Roussel P, Hernandez-Verdun D: The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron 2000;31:121-126.
17. Derenzini M, Trere D: AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralbl Pathol 1994;140:7-10.
18. Tosi P, Cintorino M, Santopietro R, Lio R, Barbini P, Ji H, Chang F, Kataja V, Syrjanen S, Syrjanen K: Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV): quantitative data and cytokeratin expression. Pathol Res Pract 1992;188:866-873.
19. Trere D, Ceccarelli C, Danova M, Derenzini M: In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours. Eur J Histochem 1996;40:17-26.
20. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey Raab S, Sherman M, Wilbur D, Wright T Jr, Young N;Forum Group Members;Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
21. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139 271-279.
22. Rabinovitch PS: DNA content histogram and cell cycle analysis. Methods Cell Biol 1994;41:263-296.
23. Baisch H, Gohde W, Linden WA: Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys 1975;12:31-39.
24. Salud A, Porcel JM, Rajkundalia B, Camplejohn RS, Taub NA: Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. J Surg Oncol 1999;72:167-174.
25. Smith PJ, Skilbeck N, Harrison A, Crocker J: The effect of a series of fixatives on the Ag-NOR technique. J Pathol 1988;155:109-112.
26. Crocker J, Boldy DR, Egan MJ: How should we count AgNORs? Proposals for a standardized approach. J Pathol 1989;158:185-188.
27. Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC: HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Int J Cancer 2005;115:419-428.
28. Reich O, Purstner P, Klaritsch P, Haas J, Lahousen M, Tamussino K, Winter R: Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer. Eur J Gynaecol Oncol 2003;24:13-17.
29. Mourad WA, Erkman-Balis B, Livingston S, Shoukri M, Cox CE, Nicosia SV, Rowlands DT Jr: Argyrophilic nucleolar organizer regions in breast carcinoma: correlation with DNA flow cytometry, histopathology, and lymph node status. Cancer 1992;69:1739-1744.
30. Huang MS, Tsai MS, Hwang JJ, Wang TH: Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion. Thorax 1994;49:1152-1156.
31. Thickett KM, Griffin NR, Griffiths AP, Wells M: A study of nucleolar organizer regions in cervical intraepithelial neoplasia and human papillomavirus infection. Int J Gynecol Pathol 1989;8:331-339.
32. Terlikowski S, Dzieciol J, Mazurek A, Sulkowski S, Boron R, Oniszczuk M, Lejmanowicz K: A morphometric study of nucleolar organiser regions in cervical intraepithelial neoplasia. Folia Morphol (Warsz) 2004:63:209-212.
33. Dey P, Das R, Sabuddin: Correlations between apoptotic and proliferative indices in cervical intraepithelial neoplasia and carcinoma. Indian J Pathol Microbiol 2000;43:271-275.
34. Sakai YI, Sakai AT, Isotani S, Cavaliere MJ, de Almeida LV, Calore EE: Morphometric evaluation of nucleolar organizer regions in cervical intraepithelial neoplasia. Pathol Res Pract 2001;197:189-192.
35. Misra JS, Das V, Srivastava AN, Singh U, Singh M: AgNOR counts in cervical smears under normal and other cytopathologic conditions. Anal Quant Cytol Histol 2005;27:337-340.
36. Johnson TS, Adelson MD, Sneige N, Williamson KD, Lee AM, Katz R: Cervical carcinoma DNA content, S-fraction, and malignancy grading. I. Interrelationships. Gynecol Oncol 1987;26:41-56.
37. Lumachi F, Ermani M, Marino F, Poletti A, Basso SM, Iacobone M, Favia G: Relationship of AgNOR counts and nuclear DNA content to survival in patients with parathyroid carcinoma. Endocr Relat Cancer 2004;11:563-569.
38. Sah SP, Dawar R, Kumar L, Gupta SD: Nucleolar organizer regions as a prognostic indicator in epithelial cancers of the ovary. Int J Gynecol Pathol 2004;23:347-353.
39. Wilailak S, Rochanawutanon M, Srisupundit S, Aumkhyan A, Pattanapanyasat K: Flow cytometric analysis of DNA ploidy and S-phase fraction of stage IIIB cervical carcinoma. Eur J Gynaecol Oncol 2004;25:428-430.
40. Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J: Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer. Cancer Radiother 2005;9:575-586.
41. Horn LC, Raptis G, Nenning H: DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b. Anal Quant Cytol Histol 2002;24:23-29.
42. Gasinska A, Krzyszkowski T, Niemiec J, Adamczyk A, Skolyszewski J: Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas. Folia Histochem Cytobiol 2000;38:175-180.